VP, Business Development
Mert joined Unum in 2019 and is responsible for leading Unum’s business development and corporate development efforts. Mert has two decades of multinational experience in pharmaceuticals and biotechnology, including leadership roles in business development and technical operations. Previously, he served as global head of hematology and immunology business development at Shire, where he led a team responsible for identification, evaluation and execution of global business development opportunities and facilitated the company’s acquisitions of Baxalta Inc. and Dyax Corp. Prior to Shire, he held positions of increasing responsibility at Biogen, ensuring clinical and commercial supply of biologics across diverse therapeutic areas. Mert received a B.S. in Chemical Engineering from Worcester Polytechnic Institute, M.S. in Engineering Management from Tufts University, and M.B.A. from the Massachusetts Institute of Technology Sloan School of Management.